Stock DNA
Pharmaceuticals & Biotechnology
CNY 11,950 Million (Large Cap)
33.00
NA
0.99%
-0.54
9.32%
3.02
Revenue and Profits:
Net Sales:
370 Million
(Quarterly Results - Mar 2026)
Net Profit:
153 Million
Total Returns (Price + Dividend) 
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
3.78%
0%
3.78%
6 Months
4.04%
0%
4.04%
1 Year
17.44%
0%
17.44%
2 Years
-47.44%
0%
-47.44%
3 Years
-39.6%
0%
-39.6%
4 Years
-39.11%
0%
-39.11%
5 Years
-67.98%
0%
-67.98%
Shanghai MicroPort Endovascular MedTech Co., Ltd. for the last several years.
Risk Adjusted Returns v/s 
News
No Recent News for the Company
Announcements 
No announcement available
Corporate Actions 
No corporate action available
Quality key factors 
Factor
Value
Sales Growth (5y)
24.78%
EBIT Growth (5y)
18.53%
EBIT to Interest (avg)
100.00
Debt to EBITDA (avg)
0
Net Debt to Equity (avg)
-0.52
Sales to Capital Employed (avg)
0.36
Tax Ratio
25.31%
Dividend Payout Ratio
48.89%
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
74.02%
ROE (avg)
16.77%
Valuation key factors
Factor
Value
P/E Ratio
33
Industry P/E
Price to Book Value
3.33
EV to EBIT
29.46
EV to EBITDA
24.36
EV to Capital Employed
6.16
EV to Sales
9.99
PEG Ratio
NA
Dividend Yield
1.08%
ROCE (Latest)
20.91%
ROE (Latest)
10.02%
Technicals key factors
Indicator
Weekly
Monthly
MACD
Mildly Bearish
Mildly Bullish
RSI
No Signal
No Signal
Bollinger Bands
Mildly Bullish
Sideways
Moving Averages
Mildly Bullish (Daily)
KST
Bullish
Mildly Bullish
Dow Theory
No Trend
No Trend
OBV
No Trend
No Trend
Shareholding Snapshot
No data for shareholding present.
Shareholding Compare (%holding) 
No data for shareholding present.
Quarterly Results Snapshot (Consolidated) - Mar'26 - QoQ
Mar'26
Dec'25
Change(%)
Net Sales
370.20
335.90
10.21%
Operating Profit (PBDIT) excl Other Income
175.60
174.50
0.63%
Interest
0.10
0.30
-66.67%
Exceptional Items
0.00
0.40
-100.00%
Consolidate Net Profit
152.60
131.60
15.96%
Operating Profit Margin (Excl OI)
474.20%
449.60%
2.46%
USD in Million.
Net Sales
QoQ Growth in quarter ended Mar 2026 is 10.21% vs 11.82% in Dec 2025
Consolidated Net Profit
QoQ Growth in quarter ended Mar 2026 is 15.96% vs 17.08% in Dec 2025
Annual Results Snapshot (Consolidated) - Dec'25
Dec'25
Dec'24
Change(%)
Net Sales
1,340.10
1,197.20
11.94%
Operating Profit (PBDIT) excl Other Income
665.30
577.70
15.16%
Interest
2.30
2.00
15.00%
Exceptional Items
0.40
56.50
-99.29%
Consolidate Net Profit
554.70
492.70
12.58%
Operating Profit Margin (Excl OI)
429.50%
431.90%
-0.24%
USD in Million.
Net Sales
YoY Growth in year ended Dec 2025 is 11.94% vs 1.78% in Dec 2024
Consolidated Net Profit
YoY Growth in year ended Dec 2025 is 12.58% vs 1.13% in Dec 2024
About Shanghai MicroPort Endovascular MedTech Co., Ltd. 
Shanghai MicroPort Endovascular MedTech Co., Ltd.
Pharmaceuticals & Biotechnology
No Details Available.
Company Coordinates 
No Company Details Available






